Mary Beth Nierengarten

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, the global cancer statistics for 2022 offer a view on disparities in the incidence and mortality of cancer by sex and region worldwide and on the areas needing attention. In addition, articles address a potential new therapy for KRAS ‐mutated colorectal cancer and inequities in breast cancer from prevention through supportive care.

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, we present findings from part one of the Annual Report to the Nation on the Status of Cancer, which provides statistics on incidence and mortality rates across cancer types and demographics. In addition, a new study shows that combining metastasis‐directed radiation therapy with intermittent hormone therapy improves progression‐free survival for advanced prostate cancer and updated American Society of Clinical Oncology guidelines on HER2‐positive breast cancer provide new recommendations based on a systematic evaluation of the best evidence to date by a panel of experts.

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. This issue addresses efforts to optimize colonoscopy measures and broaden accessibility to screening in underserved areas. In addition, people who use cannabis—particularly those with a cannabis use disorder—are significantly more likely to develop head and neck cancers than nonusers, and the combination of pembrolizumab and cabozantinib shows promising long‐term disease control and survival for head and neck cancer.

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, we take a closer look at the confusion surrounding a recent study that seemed to indicate that colonoscopies are not as effective as commonly thought at detecting colorectal cancer. In addition, new research provides a better understanding of the role of type XII collagen in the biology and progression of breast cancer, and results of a recent phase 1 study examine the feasibility, safety, and therapeutic potential of “off‐the‐shelf” chimeric antigen receptor T‐cell therapy for children with aggressive leukemia.